E.M. Berns
Department of Medical Oncology
Rotterdam Cancer Institute (Daniel den Hoed Kliniek)/University Hospital Rotterdam
Netherlands
Name/email consistency: high
- Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Berns, E.M., Foekens, J.A., Vossen, R., Look, M.P., Devilee, P., Henzen-Logmans, S.C., van Staveren, I.L., van Putten, W.L., Inganäs, M., Meijer-van Gelder, M.E., Cornelisse, C., Claassen, C.J., Portengen, H., Bakker, B., Klijn, J.G. Cancer Res. (2000)
- p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. Berns, E.M., Klijn, J.G., van Putten, W.L., de Witte, H.H., Look, M.P., Meijer-van Gelder, M.E., Willman, K., Portengen, H., Benraad, T.J., Foekens, J.A. J. Clin. Oncol. (1998)
- Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer. Berns, E.M., van Staveren, I.L., Klijn, J.G., Foekens, J.A. Breast Cancer Res. Treat. (1998)
- Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosols. Berns, E.M., De Witte, H.H., Klijn, J.G., Willman, K., Look, M.P., Meijer-Van Gelder, M.E., Benraad, T.J., Foekens, J.A. Anticancer Res. (1997)
- TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Berns, E.M., Klijn, J.G., Smid, M., van Staveren, I.L., Look, M.P., van Putten, W.L., Foekens, J.A. Genes. Chromosomes. Cancer (1996)
